Literature DB >> 29629585

Mortality and cause of death postoperatively in patients with a hip fracture: a national cohort longitudinal follow-up study.

H G Choi1, Y B Lee2, S H Rhyu2, B C Kwon2, J K Lee2.   

Abstract

Aims: The aim of this study was to compare the rate of mortality and causes of death in Korean patients who undergo surgery for a fracture of the hip, up to 11 years after the injury, with a control group from the general population. Materials and
Methods: National cohort data from Korean Health Insurance Review and Assessment Service - National Sample Cohort were used. A ratio of 1:4 matched patients with a fracture who underwent surgery (3383, fracture group) between 2003 and 2012, and controls (13 532) were included. The matches were processed for age, gender, income, and region of residence. We also undertook analyses of subgroups according to age and gender. The mean follow-up was 4.45 years (1 to 11).
Results: The prevalence of hypertension, diabetes, and stroke was significantly higher in the fracture group and dyslipidemia in the controls. Both crude and adjusted hazard ratios (HR) for the rate of mortality in the fracture group were > 2 (crude HR 2.03, 95% confidence interval (CI) 1.91 to 2.17, p < 0.001; adjusted HR 2.07, 95% CI 1.94 to 2.21, p < 0.001). The HRs were also > 2 for both men and women, and for both those aged ≥ 50 years and < 50 years. However, for those aged < 50 years, they were insignificant. The rates of mortality due to all 11 major causes of death classified following Korean standard classification of diseases were significantly higher in the fracture group compared with the control group, except those in the mental and behavioral disorders category.
Conclusion: The rate of mortality in the fracture group was significantly higher than in the control group up to 11 years after the surgery. The rate of death due to almost every major cause was significantly higher in the fracture group compared with the control group. Cite this article: Bone Joint J 2018;100-B:436-42.

Entities:  

Keywords:  Cause of death; Cohort study; Hip fracture; Mortality

Mesh:

Year:  2018        PMID: 29629585     DOI: 10.1302/0301-620X.100B4.BJJ-2017-0993.R2

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  13 in total

1.  Analysis of Factors Affecting the Third- and Twelfth-Month Mortality in Patients with Hip Fractures Aged 80 Years and Older.

Authors:  Cafer Ö Hançerli; Ali Turgut; Can E Ünlü; Cemil Ertürk
Journal:  Indian J Orthop       Date:  2021-11-29       Impact factor: 1.251

2.  β-adrenergic blockade is associated with a reduced risk of 90-day mortality after surgery for hip fractures.

Authors:  Ahmad Mohammad Ismail; Tomas Borg; Gabriel Sjolin; Arvid Pourlotfi; Sebastian Holm; Yang Cao; Per Wretenberg; Rebecka Ahl; Shahin Mohseni
Journal:  Trauma Surg Acute Care Open       Date:  2020-07-29

3.  A New Random Forest Algorithm-Based Prediction Model of Post-operative Mortality in Geriatric Patients With Hip Fractures.

Authors:  Fei Xing; Rong Luo; Ming Liu; Zongke Zhou; Zhou Xiang; Xin Duan
Journal:  Front Med (Lausanne)       Date:  2022-05-11

4.  One-year mortality in displaced intracapsular hip fractures and associated risk: a report of Chinese-based fragility fracture registry.

Authors:  Simon Kwoon-Ho Chow; Jiang-Hui Qin; Ronald Man-Yeung Wong; Wai-Fan Yuen; Wai-Kit Ngai; Ning Tang; Chor-Yin Lam; Tak-Wing Lau; Kin-Bong Lee; Kwai Ming Siu; Sze-Hung Wong; Tracy Y Zhu; Wing-Hoi Cheung; Kwok-Sui Leung
Journal:  J Orthop Surg Res       Date:  2018-09-14       Impact factor: 2.359

5.  Anti-PD-1 Antibody Administration following Hip Fracture Surgery Reverses Immune Dysfunction and Decreases Susceptibility to Infection.

Authors:  Hao Zhang; Chuying Chen; Jiusheng He; Jianzheng Zhang; Zhi Liu; Tiansheng Sun
Journal:  Mediators Inflamm       Date:  2019-04-03       Impact factor: 4.711

6.  Postoperative mortality in hip fracture patients stratified by the Revised Cardiac Risk Index: a Swedish nationwide retrospective cohort study.

Authors:  Maximilian Peter Forssten; Ahmad Mohammad Ismail; Tomas Borg; Rebecka Ahl; Per Wretenberg; Yang Cao; Carol J Peden; Shahin Mohseni
Journal:  Trauma Surg Acute Care Open       Date:  2021-07-26

7.  The association between the Revised Cardiac Risk Index and short-term mortality after hip fracture surgery.

Authors:  Maximilian Peter Forssten; Ahmad Mohammad Ismail; Gabriel Sjolin; Rebecka Ahl; Per Wretenberg; Tomas Borg; Shahin Mohseni
Journal:  Eur J Trauma Emerg Surg       Date:  2020-09-17       Impact factor: 2.374

8.  Preoperative Ascorbic Acid Levels in Proximal Femur Fracture Patients Have No Postoperative Clinical Impact, While Ascorbic Acid Levels upon Discharge Have a Major Effect on Postoperative Outcome.

Authors:  Katharina Hill-Mündel; Johannes Schlegl; Hans Konrad Biesalski; Sabrina Ehnert; Steffen Schröter; Christian Bahrs; Donatus Nohr; Andreas K Nüssler; Christoph Ihle
Journal:  J Clin Med       Date:  2019-12-26       Impact factor: 4.241

9.  The interaction between pre-admission β-blocker therapy, the Revised Cardiac Risk Index, and mortality in geriatric hip fracture patients.

Authors:  Ahmad Mohammad Ismail; Rebecka Ahl; Maximilian Peter Forssten; Yang Cao; Per Wretenberg; Tomas Borg; Shahin Mohseni
Journal:  J Trauma Acute Care Surg       Date:  2022-01-01       Impact factor: 3.697

10.  The mortality burden in patients with hip fractures and dementia.

Authors:  Ioannis Ioannidis; Ahmad Mohammad Ismail; Maximilian Peter Forssten; Rebecka Ahl; Yang Cao; Tomas Borg; Shahin Mohseni
Journal:  Eur J Trauma Emerg Surg       Date:  2021-02-27       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.